Respiratory virus infection in immunocompromised patients

Area of Science:

• Infectious Diseases
• Hematology
• Transplant Medicine

Background:

• Immunocompromised patients, particularly those undergoing marrow transplant, are highly susceptible to infections.
• Respiratory viruses pose a significant threat in this population, potentially leading to severe complications.

Purpose of the Study:

• To prospectively evaluate the incidence and clinical significance of respiratory virus infections in immunocompromised patients before and after marrow transplant.
• To determine the spectrum of respiratory viruses encountered and their association with clinical symptoms and outcomes.

Main Methods:

• Prospective evaluation of 78 immunocompromised patients undergoing marrow transplant.
• Surveillance for respiratory viruses (parainfluenza, RSV, influenza, adenovirus) before and up to 60 days post-transplant or discharge.
• Patients monitored on a fixed schedule and when respiratory symptoms developed.

Main Results:

• 19% of patients (15/78) had a respiratory virus detected.
• Parainfluenza viruses (1 and 3) and adenovirus were the most frequent pathogens.
• Infections occurred both before and after transplant, with some leading to pneumonia or disseminated disease.

Conclusions:

• Respiratory virus infections are frequent and often symptomatic in immunocompromised transplant patients.
• Early and specific viral diagnosis is clinically important due to the availability of antiviral therapies.
• This highlights the need for vigilant monitoring and prompt diagnosis in this vulnerable patient group.